Clinical Trials Directory

Trials / Completed

CompletedNCT03245749

Effect of Oily Fish Intake, Sex, Age, BMI, and APOE Genotype on Plasma Long Chain n-3 Fatty Acid Composition

Status
Completed
Phase
Study type
Observational
Enrollment
374 (actual)
Sponsor
University of Southampton · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers

Summary

The purpose of this study is to investigate the effect of habitual oily fish intake, sex, age, BMI, and APOE genotype on plasma long chain n-3 fatty acid composition.

Detailed description

The marine long chain n-3 polyunsaturated fatty acids (LC n-3 PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are beneficial to cardiovascular and cognitive health and the concentration of EPA and DHA present in blood and tissue lipids is positively correlated with these effects. As a result, national and global authorities recommend regular consumption of oily fish in order to provide approximately 500 mg EPA+DHA per day in a healthy population. However, the associations between EPA and DHA intake and blood and tissue status, and therefore physiological benefits, are highly variable and the factors influencing this heterogeneity are not well understood. This study aims to investigate the effect of habitual oily fish intake as well as sex, age, BMI, and Apolipoprotein E (APOE) genotype on LC n-3 PUFA status in plasma phosphatidylcholine, non-esterified fatty acids, cholesteryl esters and triacylglycerols in order to obtain greater knowledge of the determinants of LC n-3 PUFA status with the potential to develop more robust, and perhaps subgroup specific, recommendations for EPA and DHA intake.

Conditions

Timeline

Start date
2003-06-01
Primary completion
2005-09-01
Completion
2006-03-01
First posted
2017-08-10
Last updated
2021-07-08

Locations

5 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03245749. Inclusion in this directory is not an endorsement.